Sermo develops real-time medical mobile app for docs

Share this article:
Sermo develops real-time medical mobile app for docs
Sermo develops real-time medical mobile app for docs

Online physician community Sermo has launched a free medical app for its exclusive network of more than 120,000 physicians – called Sermo Mobile – which allows doctors to access medical information in real-time. The mobile app was built off of Sermo's current web platform, which provides an online resource to physicians nationwide, across 68 specialties, to consult and confer with on the highest quality care for their patients.

Sermo Mobile's iConsult feature is being touted as one of the biggest draws to the app, which allows a doctor to take a photograph of a physical ailment, x-ray or lab result, choose a question from the set list of applicable health queries, and send the message to relevant specialists in the Sermo network of physicians instantaneously. Other highlights of the app include easy access to the Sermo community's discussions about healthcare reform and clinical trials, the ability to author and track posts directly from a smart phone, and notifications that keep members flagged for new developments in medicine.

“Sermo Mobile allows members quick and eary access to the knowledge and expertise of leading PCPs and specialists throughout the country, anytime, anywhere,” says Sermo founder and CEO, Daniel Palestrant, MD, in a release. “Turning the concept of real-time medicine into reality has been our vision for some time, and this technology allows physicians to immediately impact patient care.”

The app is currently available on nationwide networks via the iPhone, iPad and iTouch. Sermo and partner Janssen Global Services, LLC, aim to continue working together to develop and deliver supplementary real-time services to help physicians provide the best point of care to their patients.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.